Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Clinical trial NCT05560308 · UNKNOWN
Trial details
- NCT number
- NCT05560308
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2024-08-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.